163 related articles for article (PubMed ID: 22185812)
1. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.
Woerner A; Sauvain MJ; Aebi C; Otth M; Bolt IB
Hum Vaccin; 2011 Dec; 7(12):1293-8. PubMed ID: 22185812
[TBL] [Abstract][Full Text] [Related]
2. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.
Gelinck LB; van der Bijl AE; Beyer WE; Visser LG; Huizinga TW; van Hogezand RA; Rimmelzwaan GF; Kroon FP
Ann Rheum Dis; 2008 May; 67(5):713-6. PubMed ID: 17965123
[TBL] [Abstract][Full Text] [Related]
3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
4. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
[TBL] [Abstract][Full Text] [Related]
7. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
Kapetanovic MC; Saxne T; Nilsson JA; Geborek P
Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801
[TBL] [Abstract][Full Text] [Related]
9. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
Ribeiro AC; Guedes LK; Moraes JC; Saad CG; Aikawa NE; Calich AL; França IL; Carvalho JF; Sampaio-Barros PD; Goncalves CR; Borba EF; Timenetsky Mdo C; Precioso AR; Duarte A; Bonfa E; Laurindo IM
Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
11. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients.
Torii Y; Kimura H; Ochi N; Kaneko K; Ando H; Kiuchi T; Ito Y
Vaccine; 2011 Jun; 29(25):4187-9. PubMed ID: 21513762
[TBL] [Abstract][Full Text] [Related]
13. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
Cullen G; Bader C; Korzenik JR; Sands BE
Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
[TBL] [Abstract][Full Text] [Related]
14. Immune response after influenza vaccination in children with cancer.
Matsuzaki A; Suminoe A; Koga Y; Kinukawa N; Kusuhara K; Hara T
Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
[TBL] [Abstract][Full Text] [Related]
16. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.
van Assen S; Holvast A; Telgt DS; Benne CA; de Haan A; Westra J; Kallenberg CG; Bijl M
Clin Immunol; 2010 Aug; 136(2):228-35. PubMed ID: 20421178
[TBL] [Abstract][Full Text] [Related]
17. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ
J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652
[TBL] [Abstract][Full Text] [Related]
18. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY
Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of intradermal influenza vaccine in children.
Esposito S; Daleno C; Picciolli I; Tagliaferri L; Scala A; Prunotto G; Montinaro V; Galeone C; Principi N
Vaccine; 2011 Oct; 29(44):7606-10. PubMed ID: 21855592
[TBL] [Abstract][Full Text] [Related]
20. H1N1 vaccination in pediatric renal transplant patients.
Kelen K; Ferenczi D; Jankovics I; Varga M; Molnar MZ; Sallay P; Reusz G; Langer RM; Pasti K; Gerlei Z; Szabo AJ
Transplant Proc; 2011 May; 43(4):1244-6. PubMed ID: 21620100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
